Company Filing History:
Years Active: 2016-2018
Title: Innovations of Tianzhu Yu in Pharmaceutical Chemistry
Introduction
Tianzhu Yu is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various diseases. With a total of 2 patents, his work focuses on innovative solutions for health-related challenges.
Latest Patents
One of Tianzhu Yu's latest patents is titled "Compounds as CRTH2 antagonist and uses thereof." This patent describes compounds that can be utilized as CRTH2 receptor antagonists, which are beneficial in the treatment and prevention of asthma, allergic rhinitis, and atopic dermatitis. These compounds target diseases mediated by prostaglandin D2 (PGD2) at the CRTH2 receptor.
Another significant patent is "Spiro compounds as Hepatitis C virus inhibitors." This patent discloses spiro compounds that can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. It also includes pharmaceutical compositions containing these compounds and methods for their use in treating HCV infection.
Career Highlights
Tianzhu Yu has worked with several companies throughout his career, including Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Jiancun Zhang and Yingjun Zhang. Their collaborative efforts have likely enhanced the research and development processes in which they have been involved.
Conclusion
Tianzhu Yu's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the treatment of significant health issues, showcasing the importance of innovation in the field.